Yuanbao (NASDAQ:YB) Stock Price Down 5.7% - Should You Sell?

Key Points

• Yuanbao Inc. stock declined by 5.7% to $18.53, with trading volume falling 39% from the average session volume.
• Wall Street Zen has revised Yuanbao's rating from "buy" to "hold".
• In the second quarter, several institutional investors, including WFM ASIA and JPMorgan Chase, acquired new positions in Yuanbao, indicating growing interest from hedge funds.

Yuanbao Inc. - Sponsored ADR (NASDAQ:YB - Get Free Report) traded down 5.7% during trading on Wednesday . The stock traded as low as $18.51 and last traded at $18.53. 54,001 shares changed hands during trading, a decline of 39% from the average session volume of 89,043 shares. The stock had previously closed at $19.64.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Yuanbao from a "buy" rating to a "hold" rating in a report on Sunday, June 15th.

Yuanbao Price Performance

The firm has a 50-day moving average price of $25.12.

Yuanbao (NASDAQ:YB - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The company reported $0.90 earnings per share (EPS) for the quarter. The business had revenue of $149.36 million for the quarter.

Hedge Funds Weigh In On Yuanbao

Several institutional investors have recently bought and sold shares of the company. WFM ASIA BVI Ltd acquired a new position in Yuanbao in the 2nd quarter valued at about $2,020,000. JPMorgan Chase & Co. acquired a new position in shares of Yuanbao during the second quarter worth about $454,000. Finally, Federated Hermes Inc. acquired a new position in shares of Yuanbao during the second quarter worth about $370,000.

About Yuanbao

Our mission is to protect health and well-being through technology. We are a leading technology-driven online insurance distributor in China. We take pride in pioneering the seamless integration of insurance with cutting-edge technologies, and have constructed a highly efficient full consumer service cycle engine.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.